This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Arzneimittelkommission der deutschen Ärzteschaft (1995): Kontraindikation bei Sumatriptan beachten. Dtsch Ärztebl 92: A-1546–1547
Arzneimittelkommission der deutschen Ärzteschaft (2010): Valproinsäure zur Migräneprophylaxe im Erwachsenenalter. Drug Safety Mail 2010–130
vom 17.12.2010; www.akdae.de/Arzneimittelsicherheit/Weitere/20101217.pdf; letzter Zugriff 23.05.2014
Bakola E, Skapinakis P, Tzoufi M, Damigos D, Mavreas V (2009): Anticonvulsant drugs for pediat- ric migraine prevention: an evidence-based review. Eur J Pain. 13: 893–901
Bird S, Derry S, Moore RA. Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev. 2014 May 21; 5:CD008616. doi:10.1002/14651858.CD008616.pub2 Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K (1999): Comparison of rizatriptan 10 mg vs naratriptan 2.5 mg in migraine. Eur Neurol 42: 173–179
Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M (1984): Analgetika-indu- zierter Dauerkopfschmerz. Dtsch Med Wochenschr 109: 369–373
Diener HC, Katsarava Z (2001): Medication overuse headache. Curr Med Res Opin 17 Suppl 1: s17–s21
Diener HC, Evers S, Förderreuther S, Freilinger T, Fritsche G, Gaul C, Göbel H et al. (2012): Therapie der Migräne. Entwicklungsstufe: S1Leitlinien für Diagnostik und Therapie in der Neurologie; 5. Auflage Stand: September 2012. Änderung am 21.03.2013; http://www.dgn.org/>component/content/article/45-leitlinien-der-dgn-2012/2298-ll-55-2012-therapie-der- migraene.html?q=migr%C3%A4ne; letzter Zugriff: 23.05.2014 Eiland LS, Hunt MO (2010): The use of triptans for pediatric migraines. Paediatr Drugs 12: 379–389
Food and Drug Administration (2011): FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate) http://www.fda.gov/Drugs/Drug- Safety/ucm245085.http; letzter Zugriff 23.05.2014 Gemeinsamer Bundesausschuss (2010): Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über die Änderung der Arzneimittel-Richtlinie: Anlage VI (Off- Label-Use) Valproinsäure bei der Migräneprophylaxeim Erwachsenenalter. BAnz. Nr. 190; S. 4169) vom 15.12.2010
Gruffyd-Jones K, Kies B, Middleton A, Mulder LJ, Rosjo O, Millson DS (2001): Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. Eur J Neurol 8: 237–245
Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL; CHAMP Study Group (2013): Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine. Headache 53: 799–816
Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001): Clinical features of with- drawal headache following overuse of triptans and otherheadache drugs. Neurology 57: 1694–1698
Kaube H, May A, Diener HC, Pfaffenrath V (1994): Sumatriptan. Brit Med J 308: 1573–1574
Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013a): Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010610. DOI: 10.1002/14651858.CD010610 Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013b): Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010611. DOI: 10.1002/14651858.CD010611
Limmroth V, Kazawara Z, Fritsche G, Diener HC (1999): Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 353: 378 Pringsheim T, Davenport W, Mackie G, Worthington I, Aube M, Christie SN, Gladstone J, Becker WJ; Canadian Headache Society Prophylactic Guidelines Development Group. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012; 39 (2 Suppl 2): S1–S59
Rapoport A, Winner P (2006): Nasal delivery of antimigraine drugs: clinical rationale and evi- dence base. Headache; 46 Suppl 4: S192–S201
Sandrini G, Farkkila M, Burgess G, Forster E, Haughie S, Eletriptan Steering Committee (2002): Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Neurology 59: 1210–1217
Shamliyan TA, Kane RL, Ramakrishnan R, Taylor FR (2013): Migraine in Children: Preventive Pharmacologic Treatments [Internet]. Effective Health Care Programm. Comparative Effectivness Review Number 108. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun
Soldin OP, Tonning JM; Obstetric-Fetal Pharmacology Research Unit Network (2008): Serotonin syndrome associated with triptan monotherapy. N Engl J Med 358: 2185–2186
Steiner TJ, Diener HC, MacGregor EA, Schoenen J, Muirheads N, Sikes CR (2003): Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia 23: 942–952
Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013; 40 (Suppl 3): S1–S80
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Günther, J. (2015). Migränemittel. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2015. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47186-9_31
Download citation
DOI: https://doi.org/10.1007/978-3-662-47186-9_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47185-2
Online ISBN: 978-3-662-47186-9
eBook Packages: Medicine (German Language)